Trans-splicing ribozymes are RNA-based catalysts capable of splicing RNA sequences from one transcript speci®cally into a separate target transcript. In doing so, a chimeric mRNA can be produced, and new gene activities triggered in living cells dependent on the presence of the target mRNA. Based on this ability of trans-splicing ribozymes to deliver new gene activities, a simple and versatile plating assay was developed in Saccharomyces cerevisiae for assessing and optimizing constructs in vivo. Trans-splicing ribozymes were used to splice sequences encoding a GAL4-derived transcription activator into a target transcript from a prevalent viral pathogen. The transcription activator translated from this new mRNA in turn triggered the expression of genes under the regulatory control of GAL4 upstream-activating sequences. Two of the activated genes complemented metabolic de®cien-cies in the host strain, and allowed growth on selective media. A simple genetic assay based on phenotypic conversion from auxotrophy to prototrophy was established to select ef®cient and speci®c trans-splicing ribozymes from a ribozyme library. This simple assay may prove valuable for selecting optimal target sites for therapeutic agents such as ribozymes, antisense RNA and antisense oligodeoxyribonucleotides, and for optimizing the design of the therapeutic agents themselves, in higher eukaryotes.
INTRODUCTION
RNA molecules with catalytic activities, commonly referred to as ribozymes, are potential tools for genetic manipulation. Various naturally occurring ribozymes have been dissected and used as endoribonucleases to cleave speci®c target transcripts (1±3). In general, however, these ribozymes demonstrate poor ef®ciency in vivo, and optimization has been hampered by the need to detect small reductions in target-gene activity (4, 5) . An alternative approach to ribozyme technologies might exploit the coupled cleavage and ligation reactions of naturally occurring RNA catalysts involved in splicing. In splicing reactions, intervening regions that disrupt the coding sequence of a gene are removed, and result in gene activation. Gene activation presents tremendous potential for the development of RNA-based technologies since detection of a de novo gene activity above negligible background is intrinsically easier to study than reductions in the levels of an existing gene, and the new activity can have profound effects on the phenotype of the host organism.
Group I introns are natural splicing catalysts that autocatalyze the removal of intron sequences and ligation of the exon sequences via two sequential transesteri®cation reactions (6) . Group I introns have been bisected, and co-expression of the individual components in vivo resulted in trans-splicing of exon sequences from one molecule into sequences of another, to create a unique chimeric transcript (7±9). Translation of the fusion RNA resulted in de novo gene activation. As one example, wild type globin sequences were trans-spliced into sickle globin mRNA to create`repaired' transcripts in vivo (10) . In a second example, an endotoxin was activated by trans-splicing endotoxin sequences into the coat protein mRNA of a prevalent plant virus (11) . The translated product of this fusion mRNA resulted in inhibition of cellular proliferation, and was limited to cells expressing the viral target sequences.
The latter example incorporated design parameters shown to improve the speci®city of the ribozyme for its target, and the ef®ciency of trans-splicing, relative to other designs (7, 11, 12) . The inclusion of an`extended antisense sequence' (EAS) at the 5¢ end of the ribozyme improved both the ef®ciency and speci®city for the intended target (11) . Transsplicing ef®ciency was further improved by retaining a potential P10 duplex at the 3¢ end of the catalytic core (7) . Notwithstanding these improved design parameters, it was recognized that trans-splicing ef®ciency and speci®city could be further improved.
In this paper, an in vivo, genetic approach for selecting optimized ribozymes from a library of constructs is described. Selection is by a simple Saccaromyces cerevisiae plating assay, and is based on ribozyme-mediated conversion from auxotrophy to prototrophy. Start-codon-de®cient mRNA encoding a GAL4-derived transcription activator was transspliced in frame with the desired target transcript, which, for the experiments described, was derived from the coat protein of cucumber mosaic virus (CMV) (13) . The translated product of this chimeric transcript activated downstream genes that were under the regulatory control of GAL4 upstream activating sequences (UASs): the HIS3 gene to confer histidine prototrophy, the ADE2 gene to confer adenine prototrophy and the lacZ gene to confer b-galactosidase activity.
Constructs demonstrating ef®cient splicing in vivo were selected by their ability to complement the metabolic de®ciencies in the host strain, and allow growth on selective media. These constructs were then subjected to a second plating assay that assured that the observed prototrophy was the result of trans-splicing with the desired target transcript. A more rigorous test for speci®city, in which the GAL4-derived sequences are replaced with sequences encoding a potent cytotoxin, is also described. This in vivo genetic selection scheme, unlike existing computer-based and in vitro screening approaches (14) , enables rapid identi®cation of ribozymes optimized for a particular target from large libraries in the complex cellular environment.
MATERIALS AND METHODS

Plasmid construction
Plasmids were constructed by standard procedures (15, 16) . A CMV coat protein (CP)-green¯uorescent protein (GFP) target gene and a mutant derivative were isolated as BamHI±SacI fragments from plasmids pCMV-GFP and pMUT-GFP, respectively (7, 11) . Each was sub-cloned in to the same sites of pVT103-U (17) between the ADH1 promoter and terminator sequences to create pCMV-GFP(URA3) and pMUT-GFP(URA3). For expression of the ribozymes, an SphI fragment containing the ADH1 promoter and terminator sequences from pVT103-U was inserted into the PvuII sites of pRS424 (18) by blunt-end ligation. In the resulting plasmid, pADH424, the ADH1 promoter directs transcription from the f1-strand (i.e. transcription is from the same strand as the TRP1 allele). The previously described ribozymes genes (11) with 3¢ exon sequences derived from diphtheria toxin A (DTA) chain were inserted into pADH424 as BamHI±SacI fragments to create p2ATcisRzDTA, p2ATDP5RzDTA, p2AT9RzDTA, p2AT54RzDTA and p2AT302RzDTA. A new 3¢ exon encoding amino acids 2±147 of the yeast GAL4 protein fused to amino acids 412±490 of the herpes simplex virus VP16 protein (19) was PCR ampli®ed from plasmid pBin35S-mGAL4/VP16+UASmGFP5er (J. Haseloff, unpublished) using a 5¢ primer with sequence ACTAGGTACC-CAACAATAAAGCTCCTGTCCTCC and a 3¢ primer with sequence ACTAACTAGTGGATCCTACCCACCGTAC-TCG. The PCR product was digested with KpnI and SpeI (italicized), sub-cloned into the same sites of pET17B (Novagen), and subsequently digested with KpnI and PstI. This gene fragment then replaced the DTA 3¢ exons in the above plasmids as KpnI±PstI fragments to create pcisRzGVP, pDP5RzGVP, p9RzGVP, p54RzGVP and p302RzGVP.
A XhoI site internal to the GAL4-VP16 3¢ exon (GVP) was removed from p54RzGVP by site-directed mutagenesis (20) using an oligonucleotide with sequence CCTCCTGATCTTCCCTaGAGAGGACCTCGACATGATCC (mutated nucleotide is in lower case). In doing so, codon usage was improved for yeast, without altering the amino acid sequence. The RzGVP fusion gene was then PCR ampli®ed with a 5¢ primer corresponding to a sequence in the ADH1 promoter, GCA-CAATATTTCAAGCTAT, and a 3¢ primer with sequence CCAGCTGCTGCAGACCCACCGTACTCGTCAATTCC-AAG, removing the BamHI site from the 3¢ end of the gene fragment. This PCR product was digested with XhoI (downstream of the 5¢ primer binding site in the template) and PstI (italicized), and sub-cloned into the same sites of pcisRzDTA (11) to create pcisRzGVP(DXDB). This cis-splicing construct was introduced into yeast, and the GVP 3¢ exon was functionally tested (not shown). The functional exon was then sub-cloned into p54RzGVP as a KpnI±PstI fragment to create p54RzGVP(DXDB).
Ten additional ribozyme constructs, pARzGVP, pBARzGVP, pCBARzGVP, pDCBARzGVP, pBRzGVP, pCBRzGVP, pDCBRzGVP, pCRzGVP, pDCRzGVP and pDRzGVP, were created by introducing new EAS regions into p54RzGVP(DXDB). The new sequences were created by PCR using pMUT-GFP as the template, and appropriate combinations of the following oligonucleotides: A, GAC-TTAACTCGAGACCAGTGCTGGTCGTAACCG; B, GAC-TTAACTCGAGAAAACTACCTGTTCCATGGC; C, GAC-TTAACTCGAGCCCTCGTCAACAGGATCGAGC; D, GAC-TTAACTCGAGAATACTCCAATTGGCGATG; A¢, CTT-AAGGATCCTCCAGTAGTGCAAATAAATTTAAGG; B¢, CTTAAGGATCCTGTCTCCCTCAAACTTGAC; C¢, CTT-AAGGATCCTTTTGTTGATAATGATCAGCG; and D¢, CT-TAAGGATCCCTTATTTGTATAGTTCATCC (i.e. A and A¢ created the`A' EAS, A and B¢ created the`BA' EAS, A and C¢ created the`CBA' EAS, etc.). The resulting PCR products were digested with BamHI and XhoI (italicized), and subcloned into the same site of p54RzGVP(DXDB) (see Fig. 1 for a graphic representation of target and ribozyme genes used in this study).
Test for prototrophy
Yeast manipulations were by standard protocols (21, 22) . Yeast strain PJ69-4a (MATa trp1-901 leu2-3 112 ura3-52 his3-200 gal4D gal80D LYS2::GAL1-HIS3 GAL2-ADE2 met2::GAL7-lacZ) (23) was cultured on supplemented minimal medium (SMM; synthetic dextrose minimal medium supplemented with adenine sulfate, uracil, L-tryptophan, L-histidine and L-methionine, each at 20 mg/l and L-leucine at 100 mg/l) (21). 5-Fluoro-orotic acid (5-FOA) (Sigma) was used at 1 g/l, and X-gal indicator plates, and b-galactosidase assays, were as described previously (15) .
PJ69-4a was initially transformed with pCMV-GFP(URA3) and pMUT-GFP(URA3), and selected on ±URA medium. The RzGVP constructs were then individually introduced, and selected on ±URA ±TRP medium. Single colonies were inoculated into ±URA ±TRP broth, and grown overnight at 30°C. The cultures were then diluted, and 1 Q 10 4 cells of each strain were spotted on the selective media indicated in Figure 3 .
RNA was isolated (15) from cells grown overnight in ±HIS medium, and reverse transcribed with Superscript RT II (Life Technologies) using the manufacturer's instructions. Trans-spliced cDNA was PCR ampli®ed using a 5¢ primer corresponding to a sequence in the CMV target gene, TCCAAGGAGATATATAACAATGC, and a 3¢ primer e141 Nucleic Acids Research, 2002, Vol. 30, No. 24 corresponding to a sequence in GVP region of the ribozymes, ACGTCCTCGCCGTCTAAGTGGAG. Ampli®ed cDNA was sequenced at the Cornell BioResource Center with the CMV target primer.
Genetic selection
Equal aliquots of the 13 trans-splicing RzGVP constructs (Fig. 2B) were mixed to create a RzGVP library and transformed en masse into PJ69-4a harboring either pCMV-GFP(URA3) or pMUT-GFP(URA3). Five percent of the transformation mixture (~1 Q 10 6 cells) was plated to ±URA ±TRP to determine transformation ef®ciency, and the remainders were plated to ±URA ±TRP ±HIS medium to select for effective splicing events. After 5 days of growth on ±URA ±TRP ±HIS, 24 colonies were randomly selected, patched to ±HIS medium, and grown for 2 days. Each was then patched to ±HIS +5-FOA and assayed for target-independent growth after 5 days. 5-FOA is a toxic analog of a compound in the uracil biosynthetic pathway, and only cells that have lost the URA3-encoding target plasmid are able to grow in its presence.
To characterize the RzGVP genes that conferred prototrophy for histidine, yeast strains from ±HIS plates were inoculated into ±TRP broth and grown overnight. Total DNA was isolated, and transformed into Escherichia coli strain KC8 (pyrF, leuB600, trpC, hisB463) (15) . KC8 cells transformed with RzGVP constructs were selected for tryptophan prototrophy on M9 minimal medium supplemented with uracil, L-histidine and L-leucine (40 mg/l each), and ampicillin (100 mg/l). Plasmid was isolated and analyzed by restriction digest from four KC8 colonies obtained from each yeast strain prototrophic for histidine.
Stringent test for speci®city
The GVP 3¢ exons in constructs pARzGVP, pBARzGVP, pCBARzGVP and pDCBARzGVP were replaced with the DTA 3¢ exon from pcisRzDTA (11) as KpnI±PstI fragments to create constructs pARzDTA, pBARzDTA, pCBARzDTA and pDCBARzDTA. Growth rates of PJ69-4a cultures harboring these constructs, as well as constructs pADH424, p2ATcis-RzDTA, p2ATDP5RzDTA, p2AT9RzDTA, p2AT54RzDTA and p2AT302RzDTA (see above), were measured by taking OD 600 readings of ±TRP broth cultures maintained in log phase for at least six generations.
RESULTS
Ribozyme design
The trans-splicing ribozymes used are based on the group I intron of the large ribosomal RNA subunit of Tetrahymena thermophila. This intron autocatalyzes its own excision and ligation of the exon sequences via two sequential transesteri®cation reactions (6) . The reaction mechanism of transsplicing is assumed to be the same as for cis-splicing, with the exception that the 5¢ exon is on a separate molecule from the intron and 3¢ exon, necessitating an intermolecular association via base pairing (compare Fig. 1A and B). General principles for the design and construction of trans-splicing ribozymes, and details of the reaction mechanism, were described previously (7,11).
Ribozymes designed to splice GAL4-derived transcription activator sequences into the CP mRNA of CMV were created in both cis-and trans-splicing con®gurations ( Fig. 1A and B) . Ribozymes targeted to CMV sequences are desirable as CMV is a prevalent agricultural pathogen with a host range exceeding 800 species, and is recognized as the causal agent of numerous disease epidemics worldwide (13) . To facilitate monitoring the target in the yeast assay, the CP sequences were fused in frame to sequences encoding the GFP (CMV-GFP; Fig. 1B ). The sole sequence requirement in the target mRNA is a uridine that forms a wobble base pair with a guanosine in the internal guide sequence (IGS) of the ribozyme, thereby de®ning the 5¢ splice site (24, 25) . A uridine 10 nt downstream of the CP AUG initiation codon was chosen as the 5¢ splice site. Selecting a uridine close to the initiation codon minimizes the N-terminal fusion produced after splicing to the 3¢ exon. Furthermore, selecting a splice site close to the 5¢ terminus of the target transcript may facilitate helix formation between the target and the ribozyme (4). An inactive control target was also created to gauge ribozyme speci®city by mutating this uridine to a guanosine, thereby preventing recognition of the 5¢ splice site (MUT-GFP).
Sequences in the intron IGS were altered from wild type Tetrahymena sequences to allow formation of an arti®cial helix P1 with the CMV target while maintaining the essential U:G wobble base pair at the 5¢ splice site (Fig. 1A and B) . A splicing-de®cient control ribozyme was created to monitor splicing-independent expression of the 3¢ exon. This construct, pDP5RzGVP, is identical to pcisRzGVP (Fig. 1A) , except that the P5abc region of the intron core, which is essential for splicing avtivity (26) , is deleted.
The 3¢ exon encoding a GAL4-derived transcription activator was fused downstream of the ribozyme so that splicing would result in an in frame fusion to the target coding sequence (Fig. 2C) . The GAL4-derived 3¢ exon does not contain an AUG start codon which otherwise may contribute to spurious expression. Sequences at the 5¢ end of the 3¢ exon and in the IGS were adjusted to allow formation of a P10 duplex (Fig. 1A and B) , which is hypothesized to facilitate alignment of the exons (27) , and is demonstrated to improve trans-splicing ef®ciency (7) .
Previous studies indicated that increasing the length of the EAS improves both trans-splicing ef®ciency and speci®city (7, 11) . To test the universality of this ®nding, the EAS regions in this work ranged from 0 nt (p9RzGVP) to 764 nt (pDCBARzGVP) (Fig. 1B) . Furthermore, previous transsplicing ribozyme designs incorporated an unpaired region between helix P1 and the EAS/target duplex to potentially facilitate formation of helix P10 after the ®rst transesteri®ca-tion reaction. To gauge the tolerated gap between helix P1 and the EAS/target duplex, the EASs of the ribozymes were designed to leave target sequences ranging from 5 to 605 nt unpaired, while the unpaired ribozymes sequences were maintained at 10 nt in all constructs containing an EAS (Fig. 1B) .
Complementation of metabolic de®ciencies
Yeast was selected as a eukaryotic model organism for developing and assaying the trans-splicing ribozymes since yeast is easy to manipulate, grows rapidly and well developed genetic tools are available. In addition, yeast shares many aspects of gene expression and cellular organization with higher eukaryotes that may affect ribozyme ef®cacy, but cannot be addressed in prokaryotic systems. The yeast strain used, PJ69-4a (23), has selectable marker genes downstream of GAL4-recognized UASs that are expressed only in the presence of a GAL4-derived transcription activator: the GAL1-HIS3 gene to confer histidine prototrophy, the GAL2-ADE2 gene to confer adenine prototrophy and the GAL7-lacZ gene to enable b-galactosidase assays (Fig. 1D) .
PJ69-4a cells harboring either the target construct, pCMV-GFP(URA3), or mutant target construct, pMUT-GFP(URA3), were individually transformed with each of the 15 RzGVP plasmids, and selected on ±URA ±TRP. Individual colonies were inoculated into ±URA ±TRP broth, grown overnight and 1 Q 10 4 cells of each were spotted onto selective media (Fig. 2) . Growth of all strains was rapid on ±URA ±TRP medium, as expected since selection is for the presence of target and ribozyme plasmids only (Fig. 2B) . The growth rate of strains harboring pcisRzGVP was reduced relative to the others (not shown), suggesting expression of the GAL4-VP16 transcription activator from a cis-splicing construct is strong enough to be mildly toxic. A reduction in growth rate resulting from high expression levels of GAL4-VP16 is documented (28). 
On media indicative of GAL4 activity, cells harboring pcisRzGVP were prototrophic for histidine and adenine, and b-galactosidase activity was observed (Fig. 2C, D and E, respectively), demonstrating ef®cient activation of the GAL1-HIS3, GAL2-ADE2 and GAL7-lacZ indicator genes. As expected for this cis-splicing construct, GAL4 activity was evident in the presence (Fig. 2C±E) and absence of target construct, pCMV-GFP(URA3), as evident by growth on indicator medium containing 5-FOA (Fig. 2F) . Importantly, growth on media indicative of GAL4 activity was not observed with cells expressing the inactive, internally deleted ribozyme, DP5RzGVP, indicating that complementation of the metabolic de®ciencies was strictly dependent on delivery of GAL4 activity via splicing. These results demonstrate that (i) the modi®cations made to sequences¯anking the intron catalytic core do not prevent splicing activity, (ii) splicing yields a translatable chimeric mRNA encoding a GAL4-derived transcription activator and (iii) the transcription activator with a short CMV CP-derived peptide fusion is active in binding DNA at GAL4-recognized UASs, and is able to promote transcription of the downstream genes.
For cells harboring trans-splicing ribozymes, growth on media indicative of GAL4 activity was observed in conjunction with the proper target ( Fig. 2C and D) , but not with the mutant target [pMUT-GFP(URA3); not shown], nor in the absence of target (Fig. 2F ). These results demonstrate a strict reliance on the target mRNA for expression of the GAL4 sequences fused to the trans-splicing ribozymes. On ±URA ±TRP ±HIS medium (Fig. 2C) , the relative growth rates of strains exhibiting growth were p302RzGVP > pARzGVP > pBARzGVP > p54RzGVP. The EAS lengths in these constructs are 293, 200, 401 and 45 nt, respectively. No growth was evident in the other strains. On ±URA ±TRP ±ADE medium (Fig. 2D) , growth was only observed with the trans-splicing constructs p302RzGVP, and pARzGVP (p302RzGVP > pARzGVP). The GAL2-ADE2 gene of PJ69-4a is a more stringent marker than the GAL1-HIS3 gene (23) , and it is thus not surprising that strains with limited growth on ±URA ±TRP ±HIS medium were unable to propagate on ±URA ±TRP ±ADE medium. Figure 2E demonstrates that delivery of the GAL4 activity via trans-splicing also activates the lacZ gene from the GAL7 promoter. Values obtained from quantitative b-galactosidase assays supported the ®ndings obtained by observing growth rates on ±URA ±TRP ±ADE medium: p302RzGVP confers greater GAL4 activity in the presence of the target than the other trans-splicing constructs.
To establish the accuracy of trans-splicing, total RNA was isolated from cultures harboring the target construct pCMV-GFP(URA3), and either p302RzGVP or pARzGVP.
RT±PCR was performed with a 5¢ primer corresponding to a sequence in the 5¢ exon of the target, and a 3¢ primer corresponding to a sequence in the GVP 3¢ exon of the ribozyme. The ampli®ed cDNA products were sequenced, and found to contain the expected sequence at the splice junction (AUG GAC AAA U/UU AGG UAC C; Fig. 1C ).
Genetic selection assay
Based on the ®nding that the ribozymes conferred targetdependent growth with different ef®ciencies, a genetic screen for selecting optimized trans-splicing constructs from a ribozyme library was established. It was predicted that colonies harboring the most ef®cient ribozyme constructs would predominate on selective media, relative to less ef®cient constructs. The 13 trans-splicing ribozyme constructs were mixed in equal proportions to create a ribozyme library. This library was then introduced to PJ69-4a expressing either the proper target or the mutant target, and the number of colonies growing on selective media was scored (Table 1) .
Colony development on ±URA ±TRP indicated that 1.3 Q 10 5 total transformants were obtained for strains harboring either the proper or mutant target. For the pMUT-GFP(URA3) mutant target strain, no colonies developed on ±URA ±TRP ±HIS medium, as expected from the established speci®city of the trans-splicing reaction. For the pCMV-GFP(URA3) target strain, 1140 colonies became established after 5 days of growth. Twenty-four of these were selected at random and patched to ±HIS medium, where growth was rapid (Fig. 3A) . Each was then transferred to ±HIS +5-FOA medium to assay for the maintenance of histidine prototrophy after loss of the target plasmid (Fig. 3B) . Twenty-three strains did not show growth after 5 days incubation, indicating a reliance on the URA3 encoding target plasmid for complementation of the histidine de®ciency. One strain became established on ±HIS +5-FOA medium, indicating target-independent histidine prototrophy. Since each of the plasmids in the ribozyme library was individually demonstrated to confer histidine protrophy in a target-dependent fashion, prototrophy in this strain probably resulted from a rare DNA rearrangement.
Ribozyme-encoding plasmids were rescued from each of the 24 histidine prototrophs, and identi®ed by restriction digest analysis. The 23 strains dependent on the target for histidine prototrophy contained the most ef®cient construct: p302RzGVP. This result demonstrates the effectiveness of phenotypic conversion to prototrophy for selecting the most ef®cient ribozymes from a library of constructs. The splice junction was characterized in two of the cultures that demonstrated target-dependent growth on ±HIS medium by RT±PCR and sequencing. The ampli®ed cDNA had the expected sequence (AUG GAC AAA U/UU AGG UAC C; Fig. 1C ).
Counter selection against indiscriminate splicing
The 13 trans-splicing ribozymes analyzed in this study did not complement the metabolic de®ciencies of the yeast host strain in the absence of the intended target (Fig. 2F) . Therefore, based on this criterion of phenotypic conversion to prototrophy, each demonstrated high speci®city. However, in a library of greater complexity, target-independent expression of the 3¢ exon might occur by either non-speci®c cis-or transsplicing. For non-speci®c cis-splicing, at least three criteria must be met: (i) a region upstream of the ribozyme IGS (i.e. the EAS) must be able to fold back and base pair with the IGS to form a P1 helix; (ii) this unintended helix must contain a U wobble base paired with a G in the IGS at position 4, 5 or 6 of the P1 stem to de®ne the 5¢-splice site (25, 29) ; and (iii) for translation of the spliced RNA, sequences upstream of the spurious 5¢ splice site must contain a potential AUG start codon positioned such that it is in frame with the 3¢ exon following splicing. Implicit in the third criterion is that there are no stop codons between the AUG and the 3¢ exon-encoded open reading frame of the splice product. For non-speci®c trans-splicing to occur, an unintended helix P1 must be able to form between the ribozyme IGS and a separate RNA molecule, followed by criteria (ii) and (iii) discussed for cissplicing. It is worth noting that available evidence suggests that the presence of an EAS minimizes indiscriminate interactions between the ribozyme IGS and other transcripts (11) . Nevertheless, since expression of the 3¢ exon-encoded gene could theoretically occur via indiscriminate splicing, a practical genetic selection scheme for optimized trans-splicing constructs must be able to differentiate between target-speci®c and non-speci®c events. Therefore, the target gene was maintained on a plasmid encoding the URA3 gene, and could be eliminated by plating to medium containing 5-FOA. Strains emerging from a ribozyme library on ±HIS medium, which are also able to grow on ±HIS +5-FOA medium, would harbor indiscriminate ribozymes, whereas those unable to grow on ±HIS +5-FOA medium would contain ribozymes exhibiting high target speci®city and ef®ciency.
To test whether counter selection on 5-FOA medium can effectively differentiate between desirable target-dependent ribozymes, and undesirable indiscriminate ones, the transsplicing ribozyme library was`spiked' with the self-splicing construct, pcisRzGVP, and the genetic selection assay was repeated (Table 1) . Six colonies growing on ±URA ±TRP ±HIS medium were streaked to ±HIS media, and subsequently to ±HIS +5-FOA medium (Fig. 3C and D) . Of these six strains prototrophic for histidine, two did not grow on ±HIS +5-FOA medium, indicating a dependence on the target plasmid for prototrophy. The ribozyme plasmid identi®ed in these two was the most ef®cient trans-splicing construct, p302RzGVP. Therefore, target-dependent and -independent expression of the GAL4 encoding 3¢ exon is readily differentiated by counter selection for the target plasmid.
Negative selection
Although the trans-splicing ribozymes described are speci®c enough to prevent target-independent growth on selective media (Fig. 2F) , a more stringent assay for scrutinizing spurious expression of the 3¢ exon may be desirable in certain applications. Previous work established that low levels of 3¢ exon expression could be monitored by using a 3¢ exon encoding the DTA chain polypeptide, and measuring growth rates in liquid media relative to appropriate controls (11) . In this study, we used this growth-rate assay to establish the effect of the EAS on minimizing 3¢ exon expression, since it is hypothesized that increasing EAS length improves speci®city by`shielding' the active site from non-speci®c transcripts (11) . The GVP 3¢ exons were therefore replaced with DTA sequences, and the growth rates of cultures harboring p2ATDP5DTA, p2AT9RzDTA, p2AT54RzDTA, pARzDTA, p2AT302RzDTA, pBARzDTA, pCBARzDTA and pDCBARz-DTA were established in the absence of target relative to a strain harboring the pADH424 parental plasmid (Fig. 4) . 
The doubling time of cultures harboring p2ATDP5DTA was 5% greater than those harboring pADH424. Ribozymes derived from the T.thermophila rRNA intron that lack the P5abc region are inactive (11, 26) . The increase in doubling time is therefore independent of splicing. Cultures expressing ribozymes fused to GFP sequences do not demonstrate growth reductions relative to controls, indicating that the ribozyme itself is not toxic (B. G. Ayre, unpublished). The growth rate reduction in cultures harboring p2ATDP5DTA is thus attributed to spurious expression of the DTA sequences. Translation initiation at a ribozyme internal AUG sequence, in conjunction with frame shifting events, is the simplest explanation for`leaky' expression of the 3¢ exon.
For the trans-splicing ribozymes, an inverse trend was observed between EAS length and growth rate: shorter EAS sequences had longer doubling times (Fig. 4) . Cultures expressing ribozymes with EAS lengths of 0 nt (p2ATRzDTA), 45 nt (p2AT54RzDTA) and 200 nt (pARzDTA) grew slowly relative to strains expressing the inactive ribozyme (p2ATDP5DTA). These reductions in growth rates are thus ribozyme dependent, but target independent, and may result from indiscriminate splicing. Cultures expressing a ribozyme with 293 nt of EAS (p2AT302RzDTA) grew at a rate equivalent to p2ATDP5DTA cultures, suggesting that indiscriminate splicing is minimized. Signi®cantly, strains expressing ribozymes with 401, 601 and 764 nt of EAS (pBARzDTA, pCDARzDTA and pDCBARzDTA, respectively) grew faster than the inactive ribozyme control, suggesting that the EAS region not only limits non-speci®c splicing but may also buffer potential toxicity by minimizing read-through effects. These results demonstrate the utility of this growth-rate assay for monitoring subtle differences in 3¢ exon expression among different constructs with high sensitivity.
DISCUSSION
This work arose from the question of whether or not transsplicing ribozymes could be used as a general mechanism for delivering new gene activities dependent on the presence of a particular target transcript. We previously demonstrated that similar ribozymes could deliver suf®cient cytotoxic gene activity to prevent colony formation in yeast, and could therefore potentially be used to speci®cally ablate virusinfected or malignant cells (11) . For the work presented here, it was rationalized that transcription factors, like cytotoxins, are sensitive biological indicators, with a small number of molecules being suf®cient to activate high levels of downstream gene expression. If trans-splicing ribozymes could deliver suf®cient quantities of a transcription factor, the transcription factor could in turn drive the expression of virtually any gene of interest at biologically relevant levels.
To explore this possibility, ribozymes targeted against CMV CP sequences were created with 3¢ exon sequences encoding a GAL4-derived transcription factor. Splicing was expected to result in a chimeric mRNA consisting of the transcription factor sequences fused in frame with the AUG start codon of the CMV CP target. The translation product of this mRNA was in turn expected to bind at GAL4-recognized UASs, and induce transcription of the downstream genes. The downstream genes of interest were HIS3 to confer histidine prototrophy, ADE2 to confer prototrophy for adenine and lacZ to confer b-galactosidase activity (Figs 1 and 2) .
To establish the assay, and demonstrate its utility for rapidly assessing ribozyme function in eukaryotic cells, a series of ribozymes were constructed with EASs ranging from 0 nt (p9RzGVP) to 764 nt (pDCBARzGVP) (Fig. 1B) . Previous work indicated that increasing the length of EAS improved both trans-splicing ef®ciency (7) and speci®city (11) . Consistent with previous ®ndings, increasing the length of the EAS to 293 nt resulted in increased levels of gene delivery. However, beyond this length, ef®ciency dropped. Transsplicing activity was observed with an EAS of 401 nt, but not with 601 nt or 764 nt (Fig. 2C) .
From this result, we conclude that the length of antisense sequence does not contribute directly to ribozyme ef®ciency. More likely, the EAS provides one or more short stretches of solute-exposed nucleotides which are able to base pair with solute-exposed nucleotides in the target transcript. This initial pairing would anchor the ribozyme to the target, and duplex formation between the two molecules would then align the 5¢ splice site of the target with the ribozyme active site to enable the splicing reaction. Similar mechanisms of helix formation across important regulatory sequences from an initial site of nucleation are well characterized in natural antisense interactions (30) .
Based on this theory, we propose that the ribozyme with 293 nt of extended antisense sequence is the most ef®cient because it serendipitously contains nucleotides which are best able to interact with the target. Longer antisense sequences would contain these sequences, as might shorter sequences, however the nucleotides may not be available for interaction with the target due to unique secondary and tertiary structures within the transcripts. If this model is correct, more ef®cient ribozymes with shorter antisense sequences should be possible, providing that the antisense sequences are solute-exposed and complementary to solute-exposed target sequences. However, empirical design and in vivo testing of ribozymes is laborious, and although several computer-based and in vitro technologies have been applied to optimizing ribozymes (14, 31) , they cannot predict the behavior of a transcript in the complex cellular environment.
A more ef®cient approach would be to create a population of constructs and use in vivo genetic selection to identify individuals with desirable characteristics from the pool. Phenotypic conversion from histidine auxotrophy to prototrophy in yeast was therefore used to select ribozymes with high af®nity for the CMV CP-derived target from a library of constructs. Of the strains emerging from the genetic selection assay, 24 were analyzed in detail, and 23 harbored p302RzGVP. This result correlates well with those obtained when the constructs were tested individually: yeast strains harboring the target plasmid and p302RzGVP became established on selective media more rapidly than those harboring the other trans-splicing constructs (Fig. 2C) . Selection for adenine prototrophs could similarly be used (Fig. 2D) , and assaying b-galactosidase activity (Fig. 2E) provides a further measure of relative ribozyme activity.
The trans-splicing ribozyme library was created by directional cloning of PCR-ampli®ed target gene segments, such that each ribozyme contained target sequences in the antisense orientation. This approach allowed precise analysis of de®ned constructs, but limited library complexity. Libraries of greater complexity may contain ribozymes with improved target af®nity since each unique transcript is expected to have different solute-exposed regions due to variations in secondary and tertiary structures, or protein interactions. To create libraries of greater complexity, target sequences could be sheared, or digested with Dnase I, and cloned upstream of the ribozyme catalytic core. Alternatively, a random sequence library could be constructed from synthetic oligonucleotides. The same library could then be used to select ef®cient interactions with any target transcript of interest, and the interactions would not necessarily rely on strict Watson±Crick base pairings. Non-canonical interactions, such as tetra-loop interactions with the minor groove of double-stranded RNA (32, 33) , can have greater stability than standard Watson±Crick interactions. Furthermore, most naturally occurring antisense interactions`display' antisense sequences in a loop structure terminating a duplexed stem (30, 34) . Displaying random sequences at the end of a stem±loop structure incorporated into the EAS region may similarly improve interaction between the ribozyme and the target. Random oligonucleotide libraries for selecting optimal target sites in vitro are described with 5 Q 10 9 individual ribozyme genes (14) . Libraries for in vivo screening could in principle be scaled to any size, but in practice would be subject to the same constraints that apply to yeast`two-hybrid' protein interaction screens (23) . Initial experiments with random sequence libraries are encouraging (B. G. Ayre, unpublished) .
Although a number of strategies could be used to create a ribozyme library, some individuals within the library may exhibit target-independent cis-or trans-splicing, and result in false positives. A practical genetic selection scheme for identifying ef®cient trans-splicing constructs from a large pool must therefore readily differentiate target-dependent trans-splicing from non-speci®c events. For this reason, the CMV-GFP target gene was cloned into a yeast plasmid encoding the URA3 gene, and could be selected against by plating cells on media containing 5-FOA. In an experiment to select ef®cient trans-splicing ribozymes from a library containing cis-splicing constructs, it was found that transferring colonies from ±HIS medium to ±HIS +5-FOA medium was effective in differentiating target-independent events from legitimate trans-splicing (Fig. 3) . Yeast strains that were not able to grow on ±HIS +5-FOA medium harbored the most ef®cient trans-splicing construct, p302RzGVP (Table 1) .
Trans-splicing ribozymes incorporating GAL4-derived sequences as the 3¢ exon did not confer growth to yeast on selective media in the absence of the speci®c target (Fig. 2F) , and are therefore speci®c as de®ned by the criterion of phenotypic conversion to prototrophy. However, to assess non-speci®c expression of the 3¢ exon with greater stringency, a very sensitive and straightforward assay was employed by replacing GAL4 3¢ exon sequences with those encoding DTA chain, and measuring growth rates in liquid culture. In this assay, spurious expression of the 3¢ exon was evident as increases in culture doubling time (Fig. 4) . Some of this expression was independent of ribozyme activity, as indicated by the increased doubling time of strains containing the splicing-de®cient construct, p2ATDP5DTA. Ribozymeindependent expression may result from non-canonical initiation, stop codon read-through, or frame-shift translation of the 3¢ exon (there is no in frame AUG).
With active trans-splicing RzDTA constructs, a general inverse trend was observed between the length of the EAS and spurious 3¢ exon expression. Yeast harboring constructs with relatively short EAS regions (i.e. p2AT9RzDTA, p2AT54RzDTA and pARzDTA) demonstrated 3¢ exon expression exceeding that of the splicing-de®cient control, suggesting indiscriminate splicing between these ribozymes and non-target transcripts. Ribozymes with longer EAS regions demonstrated 3¢ exon expression equivalent to, or less than, the splicing-de®cient control, supporting the premise that increasing the length of the EAS minimizes ribozyme interaction with non-targeted sequences. It was previously argued that longer EAS regions may form fortuitous secondary and tertiary interactions that exclude non-speci®c mRNAs from entering the active site. In contrast, interaction between the intended target and the EAS would initiate formation of an extended duplex and resolve these structures. The 5¢ splice site of the intended target would then enter the ribozyme active site, and accurate splicing would proceed (11) . It is noteworthy that ribozymes with the longest EAS regions, pBARzDTA, pCBARzDTA and pDCBARzDTA, demonstrated 3¢ exon expression levels less than that of the splicing-de®cient control, indicating the EAS also minimizes splicing-independent effects.
To summarize, we demonstrate that trans-splicing ribozymes can be used to deliver new transcription factors to living cells dependent on the presence of an intended mRNA target. The transcription factor can in turn drive the expression of a chosen gene, or genes, at biologically relevant levels, and have profound effects on the host organism. The array of genetic tools available and ease of manipulation make yeast an attractive model for developing RNA-based therapeutics, yet yeast has proved recalcitrant to trans-acting ribozyme technologies (35) . Our results demonstrate functionality in yeast, and the speci®c delivery of growth-promoting gene activities presents a practical approach to applying in vivo genetic selection to ribozyme development in a eukaryotic host. Optimized ribozyme designs could then be readily introduced to higher eukaryotes for toxin-mediated ablation, or induction of gene activity by a trans-activator, dependent on the presence of a speci®c target mRNA. Work is currently underway to test the trans-splicing ribozyme in higher plants. We anticipate that this technology will have broad applications in diverse ®elds such as biotechnology, therapeutics and genomic studies.
Furthermore, the genetic screen, as presented, identi®es ef®cient and speci®c associations between the target and the antisense sequences of the ribozyme. Interaction with an intended target is the ®rst and probably rate-limiting step in trans-splicing and trans-cleaving ribozyme technologies, as well as in RNA-and DNA-based antisense technologies. Trans-splicing ribozymes for genetic selection of optimal target interactions could thus be adapted to these other applications. For example, a trans-splicing ribozyme could be converted to a cleaving ribozyme by incorporating a hammerhead domain into the extended antisense region, or the group I intron could simply be deleted to create a provocative antisense design. This technology may therefore provide an in vivo alternative to computer prediction and in vitro selection of`optimized' target sites (14) , which do not take into account the inherent structure of RNA in the cellular environment, nor the extent to which proteins prevent RNA±RNA interactions. Apart from optimizing target±ribozyme interactions, the screen could also be used as an alternative to biochemical optimization of the ribozyme itself (36) .
